Lung Cancer Considered

In this episode of Lung Cancer Considered, Dr. Stephen Liu sits down with guest Dr. Harpreet Singh from the FDA to discuss the agency’s oncology drug approval process. The interview also covers how new drug approvals are handled in other countries

In this episode of Lung Cancer Considered, guests Dr. Kristin A. Higgins and Dr. Antonio Calles discuss the case of a 42-year-old woman who presents to the emergency room with right shoulder pain and a dry cough that has worsened over the previous two months. A CT scan reveals she has a four-centimeter mass in her right lobe. Her PDL-1 is 1-2 percent. She has a limited history of smoking but no co...

This new episode of Lung Cancer Considered features a discussion of the seminal trial KEYNOTE 001 and how it impacted research and clinical care for patients with lung cancer. This podcast is noteworthy because, in addition to including researcher Dr. Eddie Garon, it also features the unique perspective from Cary Parton, a patient who participated in this trial.

This episode of Lung Cancer Considered covers recent promising results with new targeted agents for NSCLC harboring a KRAS G12C mutation. Thoracic oncologists have long thought this condition was undruggable, but results presented at WCLC 2020 from the CodeBreak 100 trial provide hope that new therapies will be more readily available.

The latest edition of Lung Cancer Considered features a discussion on a virtual tumor board in mesothelioma, involving a case with a 68-year-old male, with 30 pack years smoking history who presents to the ER due to a worsening shortness of breath at rest and with exertion, unresectable mesothelioma with chest wall invasion and pleural effusion thickening with enlarged mediastinal lymph nodes and...

In this episode of Lung Cancer Considered, Dr. Sai-Hong Ignatius Ou shares his career growth and experience participating and leading breakthrough clinical trials on therapies to treat ALK positive patients with lung cancer. Dr. Ou discusses a pivotal moment at the beginning of his career when he visited the Pfizer campus in California to learn about their effort to develop a phase 1 trial examini...

This edition of Lung Cancer Considered discusses important science presented at the recently completed European Lung Cancer Congress, the multidisciplinary lung cancer meeting co-organized by ESMO and IASLC. Dr. Enriqueta Felip and Dr. Fabrice Barlesi share their interpretation of the following clinical trials presented at ELCC: Adagrasib (MRTX849) -- phase Ib expansion and phase II monotherapy co...

The latest edition of Lung Cancer Considered features a discussion on a virtual tumor board case involving squamous cell lung cancer. Our guests are Dr. Enriqueta Felip, who is a professor of medicine and section in chief, Medical Oncology and Department Director of Thoracic Oncology at the Vall d’Hebron University Hospital in Barcelona. Joining Dr. Felip is Dr. Paul Paik, an associate attending p...

This special episode of Lung Cancer Considered features a conversation between host Dr. Stephen Liu and co-host Paul Bunn. Dr. Liu and Dr. Bunn are joined by, Dr. Tal Zaks, the chief medical officer at Moderna, and Dr. Amy Moore, a trained virologist and cancer researcher. Dr. Bunn is the founding director of the University of Colorado Cancer Center, former president of IASLC and ASCO. Dr. Moore s...

The latest episode of Lung Cancer Considered features a conversation between host, Dr. Stephen Liu and Dr. Myung-Ju Ahn, professor in the Department of Hematology-Oncology at the Samsung Medical Center, Sungkyunkwan University School of Medicine in South Korea. Together they discuss Dr. Ahn's career and her work in ROS1 lung cancer.

The latest episode of Lung Cancer Considered features a conversation between host Dr. Stephen Liu and Dr. Alex Drilon, chief, early drug development at Memorial Sloan Kettering Cancer Center. Together they discuss Dr. Drilon's career and his work on RET fusions in lung cancer.

The latest episode of Lung Cancer Considered features a conversation between host Dr. Narjust Duma and Dr. Balazs Halmos, professor of oncology and chief, thoracic/head and neck oncology at Montefiore Medical Center/Albert Einstein College of Medicine in New York. Together they discuss Dr. Halmos' career and his work on EGFR mutant non-small cell lung cancer.

Lung Cancer Considered hosts Dr. Stephen Liu and Dr. Narjust Duma are joined by Dr. Ross Soo, a senior consultant in the Department of Hematology-Oncology at the National University of Cancer Institute Singapore to discuss highlights from the IASLC 2020 WCLC Singapore meeting. Dr. Soo, along with Dr. Yi-Long Wu and Dr. Daniel Tan, served as co-chair of the meeting. Together Dr. Liu, Dr. Duma and D...

Lung Cancer Considered hosts Dr. Stephen Liu and Dr. Narjust Duma share highlights, tips and tricks for navigating IASLC's World Conference on Lung Cancer Singapore this year. Listen to this podcast as you prepare for the world’s leading lung cancer event (held virtually January 28 – 31). Register for IASLC's WCLC at //wclc2020.iaslc.org/registration.

The latest episode of Lung Cancer Considered discusses women in thoracic oncology and the upcoming IASLC Women in Thoracic Oncology Event. Register now for this event. This episode features a conversation between host, Dr. Narjust Duma, and Dr. Heather Wakelee and Dr. Clarissa Mathias. Dr. Wakelee is a thoracic medical oncologist, Deputy Director of the Stanford Cancer Institute and is the Divisio...

The latest episode of Lung Cancer Considered introduces its new hosts, Dr. Stephen Liu and Dr. Narjust Duma. Dr. Liu is an associate professor at the Lombardi Cancer Center at Georgetown University School of Medicine. Dr. Duma is an assistant professor of medicine and a thoracic oncologist at the University of Wisconsin. Get to know both Dr. Liu and Dr. Duma a little more and hear what their goals...

The latest episode of Lung Cancer Considered discusses biological and molecular staging as a dimension beyond sized-based staging. This episode features a conversation between host Dr. Jack West and Dr. Daniel Boffa, professor and division chief of thoracic surgery at Yale University.

The latest episode of “Lung Cancer Considered” discusses the practice patterns and clinical trials in India and how COVID-19 has impacted the field in India. This episode features a conversation between host Dr. Jack West and Dr. Vanita Noronha, professor of medical oncology at Tata Memorial Hospital, Mumbai, India.

The latest episode of Lung Cancer Considered brings you part two of our conversation on lung cancer stigma during Lung Cancer Awareness Month. This episode features a discussion with Jill Feldman, patient advocate; Terri Conneran, a three-time lung cancer survivor and advocate and director and founder of KRAS Kickers and the director of LiveLung International Relations; Jamie L. Studts, a professo...

In the latest episode of Lung Cancer Considered, we kick off Lung Cancer Awareness Month focusing on stigma within the lung cancer community and what we can all do to understand and overcome it. This episode features a conversation between Jill Feldman, lung cancer patient advocate and co-founder of EGRF Resisters; Terri Conneran, a three-time lung cancer survivor and advocate and director and fou...

The latest episode of Lung Cancer Considered focuses on the data and clinical outcomes for patients who may go off immunotherapy after two years. This episode features a conversation between host Dr. Jack West and Dr. Matt Hellman, associate attending at Memorial Sloan Kettering Cancer Center.

In the latest episode of Lung Cancer Considered, we're going back to October 2019, pre-COVID, when Dr. Jack West interviewed Dr. Tony Mok about highlights and new research from the 2019 IASLC World Conference on Lung Cancer. We’re feeling nostalgic about being able to meet in person and heartened by how far we’ve come since our last time together.

In the latest episode of Lung Cancer Considered, three experts in thoracic oncology from around the world discuss and share their stories and experience about diversity and equity in medicine. This episode features a conversation between Dr. Narjust Duma, assistant professor of medicine - thoracic oncology at the University of Wisconsin Carbone Cancer Center; Dr. Jhanelle Gray, chair of the depart...

The latest episode of Lung Cancer Considered focuses on using digital and social media connections as an educational tool given that COVID-19 has limited in-person interactions. This episode features a conversation between host Dr. Jack West and Dr. Sanjay Mukhopadhyay, director of Pulmonary Pathology at the Cleveland Clinic.

The latest episode of Lung Cancer Considered focuses on the upcoming IASLC Liquid Biopsy Meeting that will discuss the current status of liquid biopsy in the field of thoracic. This episode features a conversation between Dr. David Gandara, director of thoracic oncology, professor emeritus, and senior advisor to the director at the UC Davis Comprehensive Cancer Center; Dr. Maria Arcila, director o...